SPG50 Phase I/II Clinical Protocol

Description

Full clinical protocol for an AAV9 gene therapy IND for SPG50, shared publicly as a model for the rare disease gene therapy community.

Providing Organization

Category

Therapeutic Modality

Jurisdiction

0 Comments